Skip to main content

Table 5 Effect of treatment with Cyclophosphamide or abnormal Savda Munziq traditional Uyghur Medicine in Mice Transplanted with S180 Tumour, on the percentage of CD 3 + , CD 4 + , CD 8 + and CD 4 /CD 8 ratio (m ± SD)

From: Immunomodulatory and antitumour effects of abnormal Savda Munziq on S180 tumour-bearing mice

Group Dosage g/kg) CD3 +T cell (%) CD4 +T cell (%) CD8 +T cell (%) CD4/CD8ratio
Control 0 60.0 ± 9.6 43.4 ± 10.1 22.9 ± 2.9 1.88 ± 0.30
Model 0 54.6 ± 9.0 37.7 ± 9.7 23.6 ± 5.8 1.62 ± 0.31
CY 0.02 53.4 ± 9.1 39.6 ± 7.6 22.0 ± 3.4 1.80 ± 0.25
ASMq 2 49.0 ± 10.9*# 28.3 ± 8.7 19.2 ± 5.8 1.52 ± 0.37
ASMq 4 58.2 ± 16.3 38.0 ± 9.0 21.1 ± 6.0 1.85 ± 0.38
ASMq 8 45.1 ± 7.8*# 28.6 ± 7.5 14.7 ± 3.0*# 1.85 ± 0.49
  1. * different from the tumour control group, *p<0.05;
  2. # different from the CY group, #p<0.05
  3. CY: cyclophosphamide.
  4. ASMq: abnormal Savda Munziq traditional Uyghur medicine.